How it works.
CJC-1295 (no DAC) is a GHRH analog that engages the GHRH receptor on pituitary somatotrophs, raising the amplitude of growth-hormone pulses. Ipamorelin is a selective agonist of the ghrelin/GHS receptor that adds to pulse frequency while sparing cortisol and prolactin. Studied together, the two pathways are reported to produce a larger, more physiological GH release than either component alone.
Each 10mg vial pairs CJC-1295 (no DAC, also called Mod GRF 1-29) with ipamorelin. The two act on distinct receptors — the GHRH receptor and the ghrelin/GHS receptor — and are most often studied together for additive, pulsatile growth-hormone release. The full per-component breakdown is disclosed on every COA.
Verified buyer notes.
Initials only — every quote is verified against an order record. We don’t ghost-write reviews.
“COA matched what we ran in-house. Powder reconstituted clean, no haze. Did exactly what we needed it to.”
“Switched after two bad lots from a previous source. Three orders in, zero issues.”
“Shipment got delayed two days by weather and still arrived at 4°C. Packaging is no joke.”
The shared signature.
06Coming soonA 15-amino-acid pentadecapeptide derived from human gastric juice, studied for its effects on tissue repair, vascular signaling, and connective-tissue research.
06Coming soonA synthetic fragment of thymosin beta-4 studied for its effects on cell migration, actin sequestration, and tissue repair signaling.
06Coming soonA 29-amino-acid GHRH analog studied for its effects on endogenous growth-hormone secretion through pituitary GHRH receptor activation.
06Coming soonA selective pentapeptide growth-hormone secretagogue studied for its effects on GH release through the ghrelin/GHS receptor, with minimal impact on cortisol or prolactin.